Why An AI Biotech Startup Launched A $600 Million Fund To Buy Stalled Drugs

Forbes – InnovationMédia · il y a 2 heures

Most AI drug development firms are focused on discovery. AI biotech Formation Bio is betting the real bottleneck is clinical trials. With a new $600 million fund to buy or license potential drugs that have stalled out,…

Extrait publié par Forbes – Innovation. Lis l'article complet sur le site d'origine.

Discussion

Rejoins la communauté pour réagir et poser tes questions.

Aucun message pour l'instant. Lance la discussion !

Why An AI Biotech Startup Launched A $600 Million Fund To Buy Stalled Drugs

Forbes – InnovationMédia · il y a 2 heures

Lire sur forbes.com

Most AI drug development firms are focused on discovery. AI biotech Formation Bio is betting the real bottleneck is clinical trials. With a new $600 million fund to buy or license potential drugs that have stalled out,…

Extrait publié par Forbes – Innovation. Lis l'article complet sur le site d'origine.

Discussion

Rejoins la communauté pour réagir et poser tes questions.

Aucun message pour l'instant. Lance la discussion !